Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
10 | 4 | IMMUNOLOGY//TRANSPLANTATION//RHEUMATOLOGY | 1369268 |
159 | 3 | CROHNS DISEASE//ULCERATIVE COLITIS//INFLAMMATORY BOWEL DISEASE | 62699 |
44 | 2 | CROHNS DISEASE//ULCERATIVE COLITIS//INFLAMMATORY BOWEL DISEASE | 31132 |
958 | 1 | INFLIXIMAB//CROHNS DISEASE//VEDOLIZUMAB | 2970 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | INFLIXIMAB | authKW | 1193383 | 19% | 20% | 560 |
2 | CROHNS DISEASE | authKW | 975962 | 35% | 9% | 1026 |
3 | VEDOLIZUMAB | authKW | 662651 | 2% | 87% | 72 |
4 | MUCOSAL HEALING | authKW | 655838 | 4% | 48% | 128 |
5 | ADALIMUMAB | authKW | 572827 | 9% | 21% | 256 |
6 | ULCERATIVE COLITIS | authKW | 482715 | 22% | 7% | 647 |
7 | INFLAMMATORY BOWEL DISEASE | authKW | 401504 | 22% | 6% | 654 |
8 | LOSS OF RESPONSE | authKW | 370128 | 1% | 81% | 43 |
9 | INFLAMMATORY BOWEL DISEASES | journal | 327045 | 10% | 10% | 297 |
10 | JOURNAL OF CROHNS & COLITIS | journal | 322180 | 6% | 16% | 185 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Gastroenterology & Hepatology | 177844 | 72% | 1% | 2132 |
2 | Pharmacology & Pharmacy | 2107 | 18% | 0% | 521 |
3 | Medicine, General & Internal | 651 | 8% | 0% | 250 |
4 | Nutrition & Dietetics | 145 | 2% | 0% | 74 |
5 | Pediatrics | 123 | 3% | 0% | 97 |
6 | Medicine, Research & Experimental | 66 | 3% | 0% | 90 |
7 | Health Care Sciences & Services | 48 | 1% | 0% | 39 |
8 | Health Policy & Services | 40 | 1% | 0% | 26 |
9 | Rheumatology | 16 | 1% | 0% | 22 |
10 | Immunology | 12 | 3% | 0% | 89 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INFLAMMATORY BOWEL DIS | 249840 | 5% | 15% | 158 |
2 | ROBARTS CLIN TRIALS | 244090 | 2% | 49% | 47 |
3 | GASTROENTEROL | 176495 | 39% | 1% | 1155 |
4 | IBD | 138679 | 2% | 20% | 65 |
5 | U954 | 122982 | 2% | 20% | 58 |
6 | UNIV HOSP NANCY | 105955 | 1% | 30% | 33 |
7 | THER EUT DIAGNOST ANTIBODIES | 100441 | 1% | 38% | 25 |
8 | NANCY UNIV HOSP | 91982 | 1% | 38% | 23 |
9 | INFLAMMATORY BOWEL DIS CLIN | 91475 | 2% | 18% | 47 |
10 | ROBARTS CLIN TRIALS INC | 75510 | 0% | 65% | 11 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | INFLAMMATORY BOWEL DISEASES | 327045 | 10% | 10% | 297 |
2 | JOURNAL OF CROHNS & COLITIS | 322180 | 6% | 16% | 185 |
3 | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 83286 | 8% | 3% | 227 |
4 | FALK SYMPOSIUM | 52880 | 2% | 8% | 61 |
5 | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | 38033 | 3% | 4% | 97 |
6 | DIGESTIVE DISEASES | 28958 | 2% | 4% | 70 |
7 | REVIEWS IN GASTROENTEROLOGICAL DISORDERS | 15586 | 0% | 15% | 10 |
8 | AMERICAN JOURNAL OF GASTROENTEROLOGY | 14640 | 4% | 1% | 127 |
9 | GUT | 12902 | 4% | 1% | 108 |
10 | DIGESTIVE AND LIVER DISEASE | 12056 | 2% | 2% | 56 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INFLIXIMAB | 1193383 | 19% | 20% | 560 | Search INFLIXIMAB | Search INFLIXIMAB |
2 | CROHNS DISEASE | 975962 | 35% | 9% | 1026 | Search CROHNS+DISEASE | Search CROHNS+DISEASE |
3 | VEDOLIZUMAB | 662651 | 2% | 87% | 72 | Search VEDOLIZUMAB | Search VEDOLIZUMAB |
4 | MUCOSAL HEALING | 655838 | 4% | 48% | 128 | Search MUCOSAL+HEALING | Search MUCOSAL+HEALING |
5 | ADALIMUMAB | 572827 | 9% | 21% | 256 | Search ADALIMUMAB | Search ADALIMUMAB |
6 | ULCERATIVE COLITIS | 482715 | 22% | 7% | 647 | Search ULCERATIVE+COLITIS | Search ULCERATIVE+COLITIS |
7 | INFLAMMATORY BOWEL DISEASE | 401504 | 22% | 6% | 654 | Search INFLAMMATORY+BOWEL+DISEASE | Search INFLAMMATORY+BOWEL+DISEASE |
8 | LOSS OF RESPONSE | 370128 | 1% | 81% | 43 | Search LOSS+OF+RESPONSE | Search LOSS+OF+RESPONSE |
9 | CERTOLIZUMAB PEGOL | 231530 | 2% | 45% | 49 | Search CERTOLIZUMAB+PEGOL | Search CERTOLIZUMAB+PEGOL |
10 | ANTI TNF | 143827 | 3% | 16% | 84 | Search ANTI+TNF | Search ANTI+TNF |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |